Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. - Wikidata - awgldk - TriplyDB

Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.

Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.

http://www.wikidata.org/entity/Q48015946

about

Antiviral activities of ISG20 in positive-strand RNA virus infections Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae Respiratory viruses other than influenza virus: impact and therapeutic advances Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS.Molecular pathology of emerging coronavirus infections Coronavirus virulence genes with main focus on SARS-CoV envelope gene Exacerbated innate host response to SARS-CoV in aged non-human primates Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection Virus-infected alveolar epithelial cells direct neutrophil chemotaxis and inhibit their apoptosis The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme A decade after SARS: strategies for controlling emerging coronaviruses A review of treatment modalities for Middle East Respiratory Syndrome.SARS: the first pandemic of the 21st century.Heterogeneous pathological outcomes after experimental pH1N1 influenza infection in ferrets correlate with viral replication and host immune responses in the lung.Pandemic 2009 H1N1 influenza virus causes diffuse alveolar damage in cynomolgus macaques.Comparison of temporal and spatial dynamics of seasonal H3N2, pandemic H1N1 and highly pathogenic avian influenza H5N1 virus infections in ferrets Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin.Advances in antivirals for non-influenza respiratory virus infections.Cynomolgus macaque as an animal model for severe acute respiratory syndrome.Nonhuman primate models for SARS.The application of genomics to emerging zoonotic viral diseases Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection.Exogenous ACE2 expression allows refractory cell lines to support severe acute respiratory syndrome coronavirus replication Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3.Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis.Pathogenesis of Influenza A/H5N1 virus infection in ferrets differs between intranasal and intratracheal routes of inoculation Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cells.Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection.Reverse genetics of SARS-related coronavirus using vaccinia virus-based recombination.Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse model MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment Identification of pulmonary Oct-4+ stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus (SARS-CoV) infection in vitro.Severe acute respiratory syndrome (SARS): lessons learnt in Hong Kong Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques.

P2860

Q24305035-5328407A-A7A2-4CA0-AFC9-7AEA65B30519 Q24648487-1B97EAC9-68DC-4679-8547-99D17C174FFC Q24655957-869CFE77-1326-4404-B037-BB40AD8A2B2E Q25256694-174F0FB8-C4DC-4795-BD21-F5301B6461F3 Q26824463-06C31B89-604A-4045-8FA9-A0A4ADBAE530 Q26827561-22DA20C8-822E-46EE-99EA-B977E4C36AF6 Q27315954-2EEF6C0A-FB25-4F1D-8822-C46AE0C2ADE1 Q27319889-57DF5D3A-445D-44FC-9D18-87C0957E03D5 Q28383088-870007AD-9D60-4FC0-BC82-87FB348BBC5E Q28575244-F97FD7B5-3836-49F2-82AE-DE02B2700CD8 Q28768791-FA003965-6E90-4710-B8DD-2B67B25BF2DA Q28817689-47B08D0F-4CE6-47CB-9E41-2D5C52890140 Q30248209-FA553305-CFA6-4AC6-BA08-76B9B5F03F3F Q30341565-D34E76E2-8AB4-4D92-A2A3-BF0D9971C52E Q30366138-4D7B5825-A564-40F8-8831-86624FC23D69 Q30391654-50492C0A-182D-4A69-A7A4-F2A451208F69 Q30420448-6F1CBC86-F3D7-4F10-AB9C-C4AD5C674AF3 Q30429521-117679FF-7403-49BE-BF8D-12C6B0F6968C Q30457132-1730F040-3B68-4B77-A034-70BA36799BD5 Q33239453-3E9701C8-AA10-40F4-BC00-C34B73380FEE Q33239624-A48BF158-1FAD-43B2-A907-C506ABC6CEA6 Q33512509-E61CE069-0E71-4C7D-A6A0-A443C9407CD6 Q33525586-7A0DF5D7-E894-4327-AEFD-878C00A42B9F Q33737690-9B44D7C5-3DCC-449D-A83F-BF35EF4DFF24 Q33755105-53147071-1AAA-477B-ACF2-5995A119D112 Q33781480-9F3DF220-FBEF-4DF1-8985-F35F94F2771D Q33843022-333CB2C9-7C23-4B26-B44D-CFB0AA5C6AC2 Q33922699-3986B489-F71F-4FF2-A7D7-E4606CF0CFB6 Q34058365-CF1EA2B0-3E87-41D8-9CF1-622E073B2471 Q34092851-880C8360-D124-4588-AFCA-56EB81B6DF9A Q34190597-D623D839-46C8-4DF5-88B6-7D29F5799E5A Q34193444-758AE67A-1977-453C-9A69-254E74B47854 Q34193942-228E0F56-47FF-4FD7-BFF8-420DE32EDA33 Q34478750-F727BA72-4FA8-4646-80B5-F173403E390A Q34650943-D94B2484-3446-4CB7-90F0-45AA9E7D973D Q34687042-8516D8D5-8F60-4F2D-B15E-85A348F89F73 Q34974298-230CE0CF-F0BB-4350-B526-416543E778FF Q34993512-9D5D05D8-59FB-4529-AAE6-1C9A5B43689A Q35036515-31BCF974-7D15-451E-8338-08F35DC52655 Q35076542-74C746F4-96F9-4A89-B7C9-301B46106AE1

P2860

Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.

http://www.wikidata.org/entity/Q48015946

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Pegylated interferon-alpha pro ...... navirus infection in macaques.

@en

Pegylated interferon-alpha pro ...... navirus infection in macaques.

@nl

type

label

Pegylated interferon-alpha pro ...... navirus infection in macaques.

@en

Pegylated interferon-alpha pro ...... navirus infection in macaques.

@nl

prefLabel

Pegylated interferon-alpha pro ...... navirus infection in macaques.

@en

Pegylated interferon-alpha pro ...... navirus infection in macaques.

@nl

P1433

Q48015946-EE975B11-BF0E-4351-B0BC-DDAE5208735F

P1476

Q48015946-2CD5BFD9-E443-4F7B-BB83-F8855AFA7FC8

P2093

Q48015946-35DA4D52-F0DF-421C-9240-403D803309C6

Q48015946-51581684-4988-4890-9150-7C730F988AAA

Q48015946-7B499E1B-6351-4500-9DA7-471F862EC085

Q48015946-81B67EE8-E565-4F53-A415-B2DF4189E0CA

Q48015946-CEE62034-C5A5-4476-90FD-B8CDD584CCE0

Q48015946-E8E7AB1C-3623-435D-8EBD-F6CB369CBC38

P2860

Q48015946-0CA39E78-3DF2-474D-B30B-764A43073356

Q48015946-12A442FB-9922-42DE-863C-11B434F0F768

Q48015946-134C531B-AA22-4A85-BFD7-5A2A676EF532

Q48015946-304CC654-BC37-4159-9E52-965AFF3D9472

Q48015946-31900AA7-B8D9-42CE-ABF3-C9A858B9AA9F

Q48015946-3560DE38-542C-4B87-81D7-2F787FFA5ECC

Q48015946-3E9D60D8-40D8-45A0-86CD-70EFE9E37CC6

Q48015946-42CD6599-1310-4179-BB73-110CE2B9EF42

Q48015946-7BD514E0-7C82-42CB-A156-4BE0823DEA5E

Q48015946-81181F2D-68CA-48BC-B49B-8C365063CDF1

P2888

Q48015946-025550BA-AE3D-48E3-9609-C9D7FB72AB5F

P304

Q48015946-DBE5C439-4F33-4582-8847-543A30DDE836

P31

Q48015946-AA352DC1-0438-49E6-8300-8806895CA1D9

P356

Q48015946-673C7C13-1F09-4221-AEBF-90CF66CA63D8

P407

Q48015946-1663DDEF-8EA5-4959-8818-585DCAAA3F53

P433

Q48015946-D5A53B17-E56B-4D72-A238-B0F2D801C548

P478

Q48015946-257035E8-8000-4593-A49C-A1B02302313B

P50

Q48015946-9A6C4133-0D73-4228-8CA1-9BB0AC6EFF5D

Q48015946-A8D21B1B-EF31-4D3D-94CA-47E84921989C

Q48015946-DECE33F6-FDF7-4447-ADE8-3347A4125D53

Q48015946-ED4ECB12-DEE1-41D3-9B03-2D26AEF7DC67

Q48015946-F1BAA0A9-BE01-4B38-9802-3034B135B494

Q48015946-F4524DAA-01F9-4830-B4BA-3DAB2D17A3C4

P577

Q48015946-3BC7CCD9-8B7C-444C-B0C3-2B2A02EB2BB1

P5875

Q48015946-4ACDBAC9-FD79-4520-8AC9-A2A8093822E0

P698

Q48015946-1F8057F5-7843-484E-AF35-515A237CE713

P921

Q48015946-2BE1DB6F-A997-4FB7-841F-449F10F06479

Q48015946-65A0F391-8691-4043-8780-AE03C1E41F25

Q48015946-6D8A2288-65BB-4828-9B92-47EB7C7BD36E

P356

P1433

Nature Medicine

P1476

Pegylated interferon-alpha pro ...... navirus infection in macaques.

@en

P2093

Byron E Martina

http://www.w3.org/2001/XMLSchema#string

Geert van Amerongen

http://www.w3.org/2001/XMLSchema#string

Kwok-Hung Chan

http://www.w3.org/2001/XMLSchema#string

Masato Tashiro

http://www.w3.org/2001/XMLSchema#string

Shigeyuki Itamura

http://www.w3.org/2001/XMLSchema#string

Ton de Jong

http://www.w3.org/2001/XMLSchema#string

P2860

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Coronavirus as a possible cause of severe acute respiratory syndrome

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

The acute respiratory distress syndrome

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

A novel coronavirus associated with severe acute respiratory syndrome

The Genome sequence of the SARS-associated coronavirus

Serum amino acids, biopterin and neopterin during long-term immunotherapy with interferon-alpha in high-risk melanoma patients.

A major outbreak of severe acute respiratory syndrome in Hong Kong.

Aetiology: Koch's postulates fulfilled for SARS virus.

P2888

P304

290-293

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM1001

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Bart L. Haagmans

Guus Rimmelzwaan

P577

2004-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6602681

http://www.w3.org/2001/XMLSchema#string

P698

14981511

http://www.w3.org/2001/XMLSchema#string

P921

severe acute respiratory syndrome-related coronavirus

severe acute respiratory syndrome coronavirus